Cargando...
Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes
Myelodysplastic syndromes (MDS) represent a heterogeneous group of acquired clonal hematopoietic disorders characterized by peripheral blood cytopenias, paradoxical BM hypercellularity, ineffective hematopoiesis, and increased risk of leukemic transformation. Risk stratification, using different pro...
Gardado en:
| Publicado en: | J Blood Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4278786/ https://ncbi.nlm.nih.gov/pubmed/25565910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S50482 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|